zithromax and Esophageal-Neoplasms

zithromax has been researched along with Esophageal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for zithromax and Esophageal-Neoplasms

Article	Year
[Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients]. Przeglad lekarski, 2003, Volume: 60, Issue:3 Septic complications are the most frequent and potentially lethal complications among patients treated for tumours. Respiratory tract infection, including pneumonia, is third most frequent of all infections occurring among patients undergoing surgical treatment. Of great clinical and pharmaeconomical importance is rational therapy with antibiotics, which lowers the risk of septic complications and sometimes even saves patients' lives. Azithromycin proved to be effective cure for environmental pneumonia. There has been presented a preliminary research on effectiveness of azithromicin in the treatment of septic pneumonia among patients treated for upper digestive tract cancers. Topics: Aged; Anti-Bacterial Agents; Azithromycin; Cross Infection; Empirical Research; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial	2003

Article

Year

[Azithromycin (Sumamed) administration in empiric treatment of nosocomial pneumonia in upper digestive tract cancer patients].

Przeglad lekarski, 2003, Volume: 60, Issue:3

Septic complications are the most frequent and potentially lethal complications among patients treated for tumours. Respiratory tract infection, including pneumonia, is third most frequent of all infections occurring among patients undergoing surgical treatment. Of great clinical and pharmaeconomical importance is rational therapy with antibiotics, which lowers the risk of septic complications and sometimes even saves patients' lives. Azithromycin proved to be effective cure for environmental pneumonia. There has been presented a preliminary research on effectiveness of azithromicin in the treatment of septic pneumonia among patients treated for upper digestive tract cancers.

Topics: Aged; Anti-Bacterial Agents; Azithromycin; Cross Infection; Empirical Research; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial

2003